Shenzhen Chipscreen Biosciences Co., Ltd. (SHA:688321)
China · Delayed Price · Currency is CNY 27.96
+1.63 (6.19%)
Jul 1, 2026, 11:29 AM CST
SHA:688321 Market Cap
SHA:688321 has a market cap or net worth of 11.66 billion as of June 30, 2026. Its market cap has increased by 27.67% in one year.
Market Cap
11.66B
Enterprise Value
11.69B
Revenue
1.00B
Ranking
n/a
PE Ratio
110.32
Stock Price
27.96
Market Cap Chart
Since August 12, 2019, SHA:688321's market cap has decreased from 39.08B to 11.66B, a decrease of -70.15%. That is a compound annual growth rate of -16.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 11.66B | -2.13% |
| Dec 31, 2025 | 11.92B | 57.27% |
| Dec 31, 2024 | 7.58B | -15.30% |
| Dec 29, 2023 | 8.95B | - |
| Dec 30, 2022 | 8.95B | -37.79% |
| Dec 31, 2021 | 14.38B | -5.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 12, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guobang Pharma | 11.50B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 11.33B |
| Zhejiang Jiuzhou Pharmaceutical | 11.32B |
| Nanjing King-Friend Biochemical Pharmaceutical | 11.04B |
| Zhejiang Garden Biopharmaceutical | 10.92B |
| Henan Lingrui Pharmaceutical | 10.91B |
| Zhejiang Medicine | 10.70B |
| Hubei Hongyuan Pharmaceutical Technology | 10.50B |